Document is current
Any future updates will be listed below
-
Authors
Hassan, Hamza http://orcid.org/0000-0003-1775-2703
Davila, Marco L. http://orcid.org/0000-0002-6270-3065
- License Information
-
More Information
Article History
First Online: 19 September 2024
Competing interests
: M.L.D. receives consulting fees from Bristol Myers Squibb, Kite/Gilead, Synthekine, A2 Biotherapeutics and Adicet. M.L.D. has equity or options with Adicet, A2 Biotherapeutics and Adaptive Biotechnologies. H.H. declares no competing interests.
